| 000 | 01700 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250518045017.0 | ||
| 264 | 0 | _c20190723 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1179-1985 | ||
| 024 | 7 |
_a10.1007/s40292-019-00323-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDel Pinto, Rita | |
| 245 | 0 | 0 |
_aLow Density Lipoprotein (LDL) Cholesterol as a Causal Role for Atherosclerotic Disease: Potential Role of PCSK9 Inhibitors. _h[electronic resource] |
| 260 |
_bHigh blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension _cJun 2019 |
||
| 300 |
_a199-207 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xadverse effects |
| 650 | 0 | 4 |
_aAtherosclerosis _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 |
_aDyslipidemias _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPCSK9 Inhibitors |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aProprotein Convertase 9 _xmetabolism |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSerine Proteinase Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGrassi, Davide | |
| 700 | 1 | _aProperzi, Giuliana | |
| 700 | 1 | _aDesideri, Giovambattista | |
| 700 | 1 | _aFerri, Claudio | |
| 773 | 0 |
_tHigh blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension _gvol. 26 _gno. 3 _gp. 199-207 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s40292-019-00323-7 _zAvailable from publisher's website |
| 999 |
_c29833658 _d29833658 |
||